Characterization of the inhibitor-resistant SHV β-lactamase SHV-107 in a clinical Klebsiella pneumoniae strain coproducing GES-7 enzyme

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 2, 2012, Pages 1042-1046

  Manageiro, Vera ^a   Ferreira, Eugénia ^a   Cougnoux, Antony ^d   Albuquerque, Luís ^b   Caniça, Manuela ^a   Bonnet, Richard ^c,d  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^b CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^c UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^d UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE SHV; BETA LACTAMASE SHV 107; CLAVULANIC ACID; GLYCINE; HYDROLASE INHIBITOR; LEUCINE; PENICILLIN G; TAZOBACTAM; THREONINE; TICARCILLIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; BACTERIAL STRAIN; BINDING AFFINITY; BINDING SITE; CATALYSIS; CONTROLLED STUDY; DRUG ANALYSIS; ESCHERICHIA COLI; IC 50; INHIBITION KINETICS; KLEBSIELLA PNEUMONIAE; MOLECULAR DYNAMICS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BINDING SITES; CLAVULANIC ACID; ENZYME INHIBITORS; FEMALE; HUMANS; KINETICS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; PNEUMONIA, BACTERIAL; PORTUGAL; SPUTUM;

EID: 84856075491     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01444-10     Document Type: Article

References (41)

1. Ambler RP, et al. 1991. A standard numbering scheme for class A β-lactamases. Biochem. J. 276:269-272.
2. Bonnet R. 2004. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48:1-14. (Pubitemid 38040170)
3. Bonnet R, et al. 2001. Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240→Gly. Antimicrob. Agents Chemother. 45:2269-2275. (Pubitemid 32664466)
4. Bonomo RA, Rice LB. 1999. Inhibitor resistant class A β-lactamases. Front. Biosci. 4:e34-e41.
5. Bush K, Jacoby JA. 2010. An updated functional classification of β-lactamases. Antimicrob. Agents Chemother. 54:969-976.
6. Caniça MM, et al. 1997. Properties of IRT-14 (TEM-45), a newly characterized mutant of TEM-type β-lactamases. Antimicrob. Agents Chemother. 41:374-378. (Pubitemid 27111033)
7. Cavallo JD, et al. 2009. Recommandations. 2009. Comité de l'antibiogramme de la Société Française de Microbiologie, Paris, France.
8. Chang F-Y, Siu LK, Fung C-P, Huang M-H, Ho M. 2001. Diversity of SHV and TEM β-lactamase in Klebsiella pneumoniae: gene evolution in northern Taiwan and two novel β-lactamases, SHV-25 and SHV-26. Antimicrob. Agents Chemother. 45:2407-2413. (Pubitemid 32801887)
9. Delmas J, Robin F, Carvalho F, Mongaret C, Bonnet R. 2006. Prediction of the evolution of ceftazidime resistance in extended-spectrum β-lactamase CTX-M-9. Antimicrob. Agents Chemother. 50:731-738. (Pubitemid 43190989)
10. Delmas J, et al. 2008. Structure and dynamics of CTX-M enzymes reveal insights into substrate accommodation by extended-spectrum β-lactamases. J. Mol. Biol. 375:192-201. (Pubitemid 350160692)
11. Drawz SM, Bonomo RA. 2010. Three decades of β-lactamase inhibitors. Clin. Microbiol. Rev. 23:160-201.
12. Du Bois SK, Marriott MS, Amyes SG. 1995. TEM-and SHV-derived extended-spectrum β-lactamases: relationship between selection, structure, and function. J. Antimicrob. Chemother. 35:7-22.
13. Dubois V, et al. 2004. SHV-49, a novel inhibitor resistant β-lactamase in a clinical isolate of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48:4466-4469. (Pubitemid 39434919)
14. Dubois V, et al. 2008. Molecular and biochemical characterization of SHV-56, a novel inhibitor-resistant β-lactamase from Klebsiella pneumoniae. Antimicrob. Agents Chemother. 52:3792-3794.
15. Dubus A, Wilkin JM, Raquet X, Normark S, Frère JM. 1994. Catalytic mechanism of active-site serine β-lactamases: role of the conserved hydroxy group of the Lys-Thr(Ser)-Gly triad. Biochem. J. 301:485-494.
16. Ferech M, et al. 2006. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. J. Antimicrob. Chemother. 58:401-407. (Pubitemid 44294954)
17. Finlay J, Miller L, Poupard JA. 2003. A review of the antimicrobial activity of clavulanate. J. Antimicrob. Chemother. 52:18-23. (Pubitemid 36850079)
18. Frère JM, Dormans C, Duyckaerts C, De Graeve J. 1982. Interaction of β-iodopenicillanate with the beta-lactamases of Streptomyces albus G and Actinomadura R39. Biochem. J. 207:437-444. (Pubitemid 13138856)
19. Gasteiger J, Rudolph C, Sadowski J. 1990. Automatic generation of 3D-atomic coordinates for organic molecules. Tetrahedron Comput. Methods 3:537-547.
20. Imtiaz U, Manavathu EK, Lerner SA, Mobashery S. 1993. Critical hydrogen bonding by serine 235 for cephalosporinase activity of TEM-1 β-lactamase. Antimicrob. Agents Chemother. 37:2438-2442. (Pubitemid 23324470)
21. Jacoby GA, Munoz-Price LS. 2005. The new β-lactamases. N. Engl. J. Med. 352:380-391.
22. Jorgensen WL, Maxwell DS, Tirado-Rives J. 1996. Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J. Am. Chem. Soc. 118:11225-11236. (Pubitemid 26399746)
23. Knox JR. 1995. Extended-spectrum and inhibitor-resistant TEM-type β-lactamases: mutations, specificity, and three-dimensional structure. Antimicrob. Agents Chemother. 39:2593-2601.
24. Kuzin AP, et al. 1999. Structure of the SHV-1 β-lactamase. Biochemistry 38:5720-5727.
25. Lakaye B, Dubus A, Lepage S, Groslambert S, Frère J-M. 1999. When drug inactivation renders the target irrelevant to antibiotic resistance: a case story with β-lactams. Mol. Microbiol. 31:89-101. (Pubitemid 29012151)
26. Manageiro V, Ferreira E, Albuquerque L, Bonnet R, Caniça M. 2010. Biochemical study of a new inhibitor-resistant β-lactamase, SHV-84, produced by a clinical Escherichia coli strain. Antimicrob. Agents Chemother. 54:2271-2272.
27. Matagne A, et al. 1995. Kinetic study of interaction between BRL 42715, β-lactamases, and D-alanyl-D-alanine peptidases. Antimicrob. Agents Chemother. 39:227-231.
28. Mendonça N, Ferreira E, Louro D, ARSIP participants, Caniça M. 2009. Molecular epidemiology and antimicrobial susceptibility of extendedand broad-spectrum β-lactamase-producing Klebsiella pneumoniae isolated in Portugal. Int. J. Antimicrob. Agents 34:29-37.
29. Mendonça N, Ferreira E, Louro D, Caniça M. 2006. Occurrence of a novel SHV-type enzyme (SHV-55) among isolates of Klebsiella pneumoniae from Portuguese origin in a comparison study for extended-spectrum β-lactamase-producing evaluation. Diagn. Microbiol. Infect. Dis. 56:415-420. (Pubitemid 44854357)
30. SHV genes. Diagn. Microbiol. Infect. Dis. 65:439-446.
31. Mendonça N, et al. 2008. The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanate inhibition. Antimicrob. Agents Chemother. 52:1806-1811. (Pubitemid 351614676)
32. Nuesch-Inderbinen MT, Kayser FH, Hachler H. 1997. Survey and molecular genetics of SHV β-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12. Antimicrob. Agents Chemother. 41:943-949. (Pubitemid 27194165)
33. Osterberg F, Morris GM, Sanner MF, Olson AJ, Goodsell DS. 2002. Automated docking to multiple target structures: incorporation of protein mobility and structural water heterogeneity in AutoDock. Proteins 46:34-40. (Pubitemid 34033574)
34. Page MG. 2008. Extended-spectrum β-lactamases: structure and kinetic mechanism. Clin. Microbiol. Infect. 14:63-74. (Pubitemid 350269187)
35. Paterson DL, Bonomo RA. 2005. Extended-spectrum β-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657-686.
36. Pitton JS. 1972. Mechanism of the bacterial resistance to antibiotics, p 15-93. In Adrian RH, et al (ed), Reviews of physiology, vol 65. Springer, Berlin, Germany.
37. Prinarakis EE, Miriagou V, Tzelepi E, Gazouli M, Tzouvelekis LS. 1997. Emergence of an inhibitor-resistant β-lactamase (SHV-10) derived from an SHV-5 variant. Antimicrob. Agents Chemother. 41:838-840. (Pubitemid 27150542)
38. Reading C, Cole M. 1977. Clavulanate: a β-lactamase-inhibiting β-lactam from Streptomyces clavuligerus. Antimicrob. Agents Chemother. 11:852-857. (Pubitemid 8119260)
39. Schmidt MW, Jr, et al. 2004. General atomic and molecular electronic structure system. J. Comput. Chem. 14:1347-1363.
40. Van Der Spoel D, et al. 2005. GROMACS: fast, flexible, and free. J. Comput. Chem. 26:1701-1718. (Pubitemid 43076182)
41. Zafaralla G, Manavathu EK, Lerner SA, Mobashery S. 1992. Elucidation of the role of arginine-244 in the turnover processes of class A β-lactamases. Biochemistry 31:3847-3852.